Print Page     Close Window     

SEC Filings

20-F
AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document
 

 

 

TABLE OF CONTENTS

 

ARTICLE 1 DEFINITIONS 1
     
ARTICLE 2 GRANT OF RIGHTS 19
     
  2.1 Grants to Lilly. 19
  2.2 Grants to ACI. 19
  2.3 Sublicenses. 20
  2.4 Retention of Rights. 21
  2.5 Disclosure of Know-How and Regulatory Documentation. 21
  2.6 Confirmatory Patent License; License Registration. 22
  2.7 Exclusivity; Change of Control of ACI. 22
     
ARTICLE 3 DEVELOPMENT AND REGULATORY ACTIVITIES 23
     
  3.1 Development. 23
  3.2 Unilateral Clinical Development Option. 26
  3.3 Regulatory Activities. 29
     
ARTICLE 4 COMMERCIALIZATION 30
     
  4.1 In General. 30
  4.2 Diligence. 30
  4.3 Booking of Sales; Distribution. 31
  4.4 Statements and Compliance with Applicable Law. 31
  4.5 Markings. 31
  4.6 Subcontracting; Distributors. 31
  4.7 Co-Promotion Option. 31
     
ARTICLE 5 COLLABORATION MANAGEMENT 31
     
  5.1 Joint Steering Committee. 31
  5.2 General Provisions Applicable to the JSC. 32
     
ARTICLE 6 SUPPLY 35
     
  6.1 Supply of Licensed Products 35
  6.2 Manufacturing Technology Transfer. 36
     
ARTICLE 7 PAYMENTS AND RECORDS 36
     
  7.1 Upfront Payment 36
  7.2 Milestones 36
  7.3 Royalties 39
  7.4 Estimated Sales Levels. 40
  7.5 Royalty Payments and Reports. 41
  7.6 Development Costs. 41
  7.7 Mode of Payment. 42
  7.8 Taxes. 43
  7.9 Interest on Late Payments. 44
  7.1 Financial Records. 44
  7.11 Audit. 44
  7.12 Right to Offset. 45

 

 i


© AC Immune 2015